Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
3.770
+0.220 (6.20%)
At close: Oct 15, 2025, 4:00 PM EDT
3.790
+0.020 (0.53%)
After-hours: Oct 15, 2025, 7:51 PM EDT
Nuvation Bio Market Cap
Nuvation Bio has a market cap or net worth of $1.29 billion as of October 15, 2025. Its market cap has increased by 68.31% in one year.
Market Cap
1.29B
Enterprise Value
740.41M
1-Year Change
68.31%
Ranking
Category
Stock Price
$3.77
Market Cap Chart
Since August 26, 2020, Nuvation Bio's market cap has increased from $174.48M to $1.29B, an increase of 639.56%. That is a compound annual growth rate of 47.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2025 | 1.29B | 44.13% |
| Dec 31, 2024 | 895.27M | 170.80% |
| Dec 29, 2023 | 330.61M | -21.16% |
| Dec 30, 2022 | 419.31M | -77.35% |
| Dec 31, 2021 | 1.85B | 779.62% |
| Dec 31, 2020 | 210.45M | 20.62% |
| Aug 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |